| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 3.770.700.990 $ | -800.202.388 $ | -18,5 % | 6 | 4.939.420.175 $ | +1.682.932.332 $ | +74,8 % | 6 | 3.597.865.094 $ | +1.635.270.184 $ | +100,3 % | 5 | ||||
| INSMED Inc | INSM | → 0 | Neutral | 2.576.570.811 $ | -1.067.703.382 $ | -29,3 % | 1 | 3.644.274.193 $ | +746.477.109 $ | +25,8 % | 1 | 2.897.797.084 $ | +973.200.741 $ | +50,6 % | 1 |
| BELITE BIO, INC | BLTE | → 0 | Stark | 456.104.722 $ | -30.810.635 $ | -6,3 % | 1 | 486.915.357 $ | +486.915.357 $ | 1 | |||||
| Abivax S.A. | ABVX | → 0 | Schwach | 352.068.686 $ | -87.645.142 $ | -19,9 % | 1 | 439.713.828 $ | +176.015.960 $ | +66,7 % | 1 | 263.697.868 $ | +263.697.868 $ | 1 | |
| UNITED THERAPEUTICS Corp | UTHR | → 0 | Neutral | 317.617.251 $ | +317.617.251 $ | 1 | |||||||||
| Cidara Therapeutics, Inc. | → 0 | 220.180.877 $ | +125.187.986 $ | +131,8 % | 1 | 94.992.891 $ | +56.994.324 $ | +150,0 % | 1 | ||||||
| Revolution Medicines, Inc. | RVMD | → 0 | Schwach | 204.983.479 $ | +204.983.479 $ | 1 | |||||||||
| Roivant Sciences Ltd. | ROIV | → 0 | Schwach | 179.516.693 $ | +179.516.693 $ | 1 | |||||||||
| Wave Life Sciences Ltd. | WVE | → 0 | Neutral | 125.167.920 $ | +125.167.920 $ | 1 | |||||||||
| uniQure N.V. | QURE | → 0 | Schwach | 23.760.000 $ | +23.760.000 $ | 1 | |||||||||
| CAPRICOR THERAPEUTICS, INC. | CAPR | → 0 | Schwach | 23.168.000 $ | +23.168.000 $ | 1 | |||||||||
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Neutral | 1.456.599 $ | +1.456.599 $ | 1 | |||||||||
| 3.770.700.990 $ | -800.202.388 $ | -18,5 % | 6 | 4.939.420.175 $ | +1.682.932.332 $ | +74,8 % | 6 | 3.597.865.094 $ | +1.635.270.184 $ | +100,3 % | 5 | ||||